|
| 36373660 | CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase. | Nucleic Acids Res | 2023 |
| 36373660 | CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase. | Nucleic Acids Res | 2023 |
| 35101336 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 36214808 | Culture-Independent Raman Spectroscopic Identification of Bacterial Pathogens from Clinical Samples Using Deep Transfer Learning. | Anal Chem | 2022 |
| 35624339 | A community approach to the cancer-variant-interpretation bottleneck. | Nat Cancer | 2022 |
| 35366592 | Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions. | Cancer Genet | 2022 |
| 36063163 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35101336 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35366592 | Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions. | Cancer Genet | 2022 |
| 35624339 | A community approach to the cancer-variant-interpretation bottleneck. | Nat Cancer | 2022 |
| 36214808 | Culture-Independent Raman Spectroscopic Identification of Bacterial Pathogens from Clinical Samples Using Deep Transfer Learning. | Anal Chem | 2022 |
| 36063163 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 32644817 | Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices. | JCO Clin Cancer Inform | 2020 |
| 31990579 | Evidence-Based Network Approach to Recommending Targeted Cancer Therapies. | JCO Clin Cancer Inform | 2020 |
| 32644817 | Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices. | JCO Clin Cancer Inform | 2020 |
| 31990579 | Evidence-Based Network Approach to Recommending Targeted Cancer Therapies. | JCO Clin Cancer Inform | 2020 |
| 31199921 | Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells. | Am J Pathol | 2019 |
| 32025647 | A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients. | JAMIA Open | 2019 |
| 31645350 | A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen). | Cold Spring Harb Mol Case Stud | 2019 |
| 31779674 | Standard operating procedure for curation and clinical interpretation of variants in cancer. | Genome Med | 2019 |
| 31199921 | Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells. | Am J Pathol | 2019 |
| 31645350 | A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen). | Cold Spring Harb Mol Case Stud | 2019 |
| 32025647 | A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients. | JAMIA Open | 2019 |
| 31779674 | Standard operating procedure for curation and clinical interpretation of variants in cancer. | Genome Med | 2019 |
| 29218886 | ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research. | Pac Symp Biocomput | 2018 |
| 31930186 | Future of Evidence Synthesis in Precision Oncology: Between Systematic Reviews and Biocuration. | JCO Precis Oncol | 2018 |
| 35135129 | Eye-Tracking Study to Enhance Usability of Molecular Diagnostics Reports in Cancer Precision Medicine. | JCO Precis Oncol | 2018 |
| 30311370 | Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards. | Hum Mutat | 2018 |
| 29888062 | Standardizing And Democratizing Access To Cancer Molecular Diagnostic Test Data From Patients To Drive Translational Research. | AMIA Jt Summits Transl Sci Proc | 2018 |
| 30576489 | iTextMine: integrated text-mining system for large-scale knowledge extraction from the literature. | Database (Oxford) | 2018 |
| 29218886 | ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research. | Pac Symp Biocomput | 2018 |
| 29545332 | Acquired Resistance to a MET Antibody <i>In Vivo</i> Can Be Overcome by the MET Antibody Mixture Sym015. | Mol Cancer Ther | 2018 |
| 35135129 | Eye-Tracking Study to Enhance Usability of Molecular Diagnostics Reports in Cancer Precision Medicine. | JCO Precis Oncol | 2018 |
| 31930186 | Future of Evidence Synthesis in Precision Oncology: Between Systematic Reviews and Biocuration. | JCO Precis Oncol | 2018 |
| 29888062 | Standardizing And Democratizing Access To Cancer Molecular Diagnostic Test Data From Patients To Drive Translational Research. | AMIA Jt Summits Transl Sci Proc | 2018 |
| 30576489 | iTextMine: integrated text-mining system for large-scale knowledge extraction from the literature. | Database (Oxford) | 2018 |
| 30311370 | Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards. | Hum Mutat | 2018 |
| 29545332 | Acquired Resistance to a MET Antibody <i>In Vivo</i> Can Be Overcome by the MET Antibody Mixture Sym015. | Mol Cancer Ther | 2018 |
| 27888622 | Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment. | Oncotarget | 2017 |
| 29261751 | eGARD: Extracting associations between genomic anomalies and drug responses from text. | PLoS One | 2017 |
| 27888622 | Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment. | Oncotarget | 2017 |
| 29261751 | eGARD: Extracting associations between genomic anomalies and drug responses from text. | PLoS One | 2017 |
| 27082433 | Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study. | PLoS One | 2016 |
| 27434074 | Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study. | PLoS One | 2016 |
| 27242035 | MET network in PubMed: a text-mined network visualization and curation system. | Database (Oxford) | 2016 |
| 27082433 | Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study. | PLoS One | 2016 |
| 27589961 | Overview of the interactive task in BioCreative V. | Database (Oxford) | 2016 |
| 27814769 | Somatic cancer variant curation and harmonization through consensus minimum variant level data. | Genome Med | 2016 |
| 27589961 | Overview of the interactive task in BioCreative V. | Database (Oxford) | 2016 |
| 27814769 | Somatic cancer variant curation and harmonization through consensus minimum variant level data. | Genome Med | 2016 |